Download our eBook

Learn how Pfizer, Roivant, and mAbxience accelerate their process development strategy

Industry contributors:

Pfizer
Roivant Sciences
mAbxience
GE Healthcare Life Sciences

The latest process development trends in biomanufacturing

When transferring a new process from lab to production, biomanufacturers face a host of challenges to:

  • increase productivity,
  • reduce cost,
  • mitigate risk, and
  • bring new products to market faster at a global scale.

Several biomanufacturers have successfully navigated these issues in the development of mAbs, vaccines, and novel biotherapies for rare diseases by tapping into external capacity and expertise.

In this eBook we share insights into some of the latest process development trends in biomanufacturing.

Download your eBook